Infectious Disease Research (HAI-IDR)

 

The main objective of the collaborative Helmholtz-Alberta Initiative (HAI) program in the field of Infectious Disease Research (IDR) is to tackle unmet needs in the development of preventative vaccines and treatments of liver disease caused by hepatitis B and C viruses.

Currently there are more than half a billion people chronically infected with HBV and HCV. The majority of individuals infected become chronic carriers of these infections. By joining complementary world-class expertise and resources in the fight against hepatitis, the University of Alberta (UofA) and Helmholtz Association (HA) will contribute to confine the spread of hepatitis and prevent future infections, help the current hepatitis patients, and reduce the disease’s immense healthcare economic burdens.

In addition to its research program, the HAI-IDR also contains an integrated education and training program for the next generation of scientists, and promotes technology transfer to benefit Alberta, Germany, and the world. In the long run, the HAI-IDR envisions expanding into other viral diseases and helping meet emerging and future infectious diseases head on.

The research program focuses on the themes therapeutics and vaccines. These themes comprise activities including:

Research Coordinators

Dr Carlos A. Guzman
Helmholtz Centre for Infection Research Dept. Medical Microbiology & Immunology
Braunschweig, Germany

Dr Lorne Tyrrell
Dept. Vaccinology & Applied Microbiology
Li Ka Shing Institute of Virology
University of Alberta
Edmonton, Alberta, Canada

Research Partners: